Evidence map›Paper›PMID 36164720›Full record

ArticleChembiochem : a European journal of chemical biology2023

Sticking the Landing: Enhancing Liposomal Cell Delivery using Reversible Covalent Chemistry and Caged Targeting Groups.

Jinchao Lou, Megan L Qualls, Michael D Best

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jinchao LouDepartment of Chemistry, University of Tennessee, 1420 Circle Drive, 37996, Knoxville, TN, USA.ORCID 0000-0001-5064-761X
Megan L QuallsDepartment of Chemistry, University of Tennessee, 1420 Circle Drive, 37996, Knoxville, TN, USA.
Michael D BestDepartment of Chemistry, University of Tennessee, 1420 Circle Drive, 37996, Knoxville, TN, USA.ORCID 0000-0001-8737-5910

Funding

Liposome Targeting and Triggered Release Driven by Reactive Oxygen SpeciesR15GM146193 · NIGMS · UNIVERSITY OF TENNESSEE KNOXVILLE · PI BEST, MICHAEL D. · 2022 to 2022
$459k
National Institute of General Medical Sciences of the National Institutes of Health NIH R15GM146193National Science Foundation DMR-1807689NIGMS NIH HHS R15 GM146193
6 · The paper itself

Abstract

Liposomes are highly effective nanocarriers for encapsulating and delivering a wide range of therapeutic cargo. While advancements in liposome design have improved several pharmacological characteristics, an important area that would benefit from further progress involves cellular targeting and entry. In this concept article, we will focus on recent progress utilizing strategies including reversible covalent bonding and caging groups to activate liposomal cell entry. These approaches take advantage of advancements that have been made in complementary fields including molecular sensing and chemical biology and direct this technology toward controlling liposome cell delivery properties. The decoration of liposomes with groups including boronic acids and cyclic disulfides is presented as a means for driving delivery through reaction with functional groups on cell surfaces. Additionally, caging groups can be exploited to activate cell delivery only upon encountering a target stimulus. These approaches provide promising new avenues for controlling cell delivery in the development of next-generation liposomal therapeutic nanocarriers.

Indexed as

Drug Delivery SystemsLiposomesCell MembraneDisulfidesDrug CarriersDisulfidesDrug CarriersLiposomescaged targetingdrug deliverylipidsliposomesreversible covalent chemistry

Identifiers

PMID36164720
PMCPMC9985139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.